Company Filing History:
6 out of 447 
4 out of 20 
Years Active: 2000-2022
Title: Innovations by Michael Weinfeld: Pioneering Advances in Cancer Research
Introduction: Michael Weinfeld is a renowned inventor based in Edmonton, Canada, with an impressive portfolio of six patents. His groundbreaking work primarily focuses on the field of cancer research, specifically in developing innovative compounds with potential therapeutic applications.
Latest Patents: Among his latest patents, Weinfeld has introduced imidopiperidine compounds as inhibitors of human polynucleotide kinase phosphatase. This work outlines the significance of these compounds in targeting critical pathways in cancer cells. Additionally, his research into synthetic lethality in cancer provides novel compounds, compositions, and methods aimed at inducing synthetic lethality in cancer cells, showcasing his commitment to improving cancer treatment strategies.
Career Highlights: Throughout his career, Michael Weinfeld has made significant contributions to both academic and healthcare institutions. He has worked with The Governors of the University of Alberta and Alberta Health Services, where he has furthered the research and application of his innovative findings in real-world medical contexts.
Collaborations: Weinfeld has had the privilege of collaborating with esteemed colleagues, including Dennis Hall and Todd Randall Mereniuk. These partnerships have enriched his research and enhanced the impact of his inventions in the fight against cancer.
Conclusion: Michael Weinfeld's work continues to push the boundaries of cancer research through his innovative approaches and solutions. His dedication to developing effective therapies is not only noteworthy but also essential in advancing medical science for the benefit of patients worldwide.